In a study published in 2019, a class of molecular high-grade diffuse large B-cell lymphoma (MHG) was defined, which had significantly higher mutation frequencies than GCB in KMT2D, BCL2, MYC, or DDX3X. The gene discussed is DDX3X; the disease is diffuse large B-cell lymphoma.